Open Access
Volume 19, Number 2, May 2012
Page(s) 183 - 188
Published online 15 May 2012
  1. Al-Aghbar M.A., Al-Qaoud K.M. & Abdel-Hafez S.K. Immunomodulatory effects of cytokine genes in mice immunized with the second subunit of Echinococcus granulosus antigen B gene. International Journal of Integrative Biology, 2008, 4 (2), 31–38. [Google Scholar]
  2. Al-Qaoud K.M., Al-Qurran L.T. & Abdel-Hafez S.K. Cytokine and antibody response to immunization of BALB/c mice with Echinococcus granulosus using various routes. Jordan Journal of Biological Sciences, 2008, 1 (3), 109–115. [Google Scholar]
  3. Bradford M. A rapid and sensitive method of quantification of microgram quantities of protein utilizing the principle of dye binding. Analytical Biochemistry, 1976, 72, 248–254. [CrossRef] [PubMed] [Google Scholar]
  4. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assay. Journal of Molecular Endocrinology, 2000, 25, 169–193. [CrossRef] [PubMed] [Google Scholar]
  5. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C.S., Greenberg H.B. & Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticules. Journal of Virology, 1998, 72 (7), 5757–5761. [PubMed] [Google Scholar]
  6. Cruz-Revilla C., Sonabend A.M., Rosas G., Toledo A., Meneses G., Lopez-Casillas F., Hernandez B., Fragoso G. & Sciutto E. Intrahepatic DNA vaccination: unexpected increased resistance against murine cysticercosis induced by nonspecific enhanced immunity. Journal of Parasitology, 2006, 92 (3), 655–657. [CrossRef] [Google Scholar]
  7. Ding J.B., Ma X.M., Wei X.L., Jia H.Y., Mamuti W., Lin R.Y., Hou M. & Wen H. Th1 and Th2 cytokines in mice infected with Echinococcus granulosus and immunized with Eg95 genetic vaccine. Cell Biology International, 2008, 32 (3), 48–49. [CrossRef] [PubMed] [Google Scholar]
  8. Dupuy C., Buzoni-Gatel D., Touze A., Bout D. & Coursaget P. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes. Journal of Virology, 1999, 73 (11), 9063–9071. [PubMed] [Google Scholar]
  9. Eckert J. & Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clinical Microbiology Reviews, 2004, 17, 107–135. [CrossRef] [PubMed] [Google Scholar]
  10. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C. & Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and Gene-Gun inoculations. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90, 11478–11482. [CrossRef] [PubMed] [Google Scholar]
  11. Holmgren J. & Czerkinsky C. Mucosal immunity and vaccines. Nature Medicine, 2005, 11 (4), 45–52. [CrossRef] [PubMed] [Google Scholar]
  12. Ivory C. & Chadee K. DNA vaccines: designing strategies against parasitic infections. Genetic Vaccines and Therapy, 2004, 2 (1), 17–25. [CrossRef] [PubMed] [Google Scholar]
  13. Jones H.P., Hodge L.M., Fujihashi K., Kiyono H., McGhee J.R. & Simecka J.W. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. Journal of Immunology, 2001, 167 (8), 4518–4526. [Google Scholar]
  14. Li B.W., Rush A., Zhang S.R., Curtis K.C. & Weil G. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filaria Journal, 2004, 3, 1–8. [CrossRef] [PubMed] [Google Scholar]
  15. Liu L., Zhou X., Liu H., Xiang L. & Yuan Z. CpG motif acts as a “danger signal” and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology, 2005, 115 (2), 223–230. [CrossRef] [PubMed] [Google Scholar]
  16. Maloy K.J., Erdmann I., Basch V., Sierro S., Kramps T.A., Zinkernagel R.M., Oehen S. & Kundig T.M. Intralymphatic immunization enhances DNA vaccination. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98 (6), 3299–3303. [CrossRef] [PubMed] [Google Scholar]
  17. Mamuti W., Sako Y., Nakao M., Xiao N., Nakaya K., Ishikawa Y., Yamasaki H., Lightowlers M.W. & Ito A. Recent advances in characterization of Echinococcus antigen B. Parasitology International, 2006, 55, 57–62. [CrossRef] [Google Scholar]
  18. Muzulin P.M., Kamenetzky L., Gutierrez A.M., Guarnera E.A. & Rosenzvit M.C. Echinococcus granulosus antigen B gene family: further studies of strain polymorphism at the genomic and transcriptional levels. Experimental Parasitology, 2008, 118, 156–164. [CrossRef] [PubMed] [Google Scholar]
  19. Oriol R., Williams J.F., Esandi M.V. & Oriol C. Purification of lipoprotein antigens of Echinococcus granulosus from sheep hydatid fluid. The American Journal of Tropical Medicine and Hygiene, 1971, 20, 569–574. [PubMed] [Google Scholar]
  20. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E. & Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proceedings of the National Academy of Sciences of the United States of America, 1999, 96 (3), 1036–1041. [CrossRef] [PubMed] [Google Scholar]
  21. Riganò R., Buttari B., de Falco E., Profumo E., Ortona E., Margutti P., Scottà C., Teggi A. & Siracusano A. Echinococcus granulosus-specific T-cell lines derived from patients at various clinical stages of cystic echinococcosis. Parasite Immunology, 2004, 26 (1), 45–52. [CrossRef] [PubMed] [Google Scholar]
  22. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Gorai I., Hirahara F., Mohri H. & Okuda K. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant Vaccine. Infection and Immunity, 1998, 66 (2), 823–826. [PubMed] [Google Scholar]
  23. Scheerlinck J.P., Casey G., McWaters P., Kelly J., Woollard D., Lightowlers M.W., Tennent J.M. & Chaplin P. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. vaccine, 2001, 19, 4053–4060. [CrossRef] [PubMed] [Google Scholar]
  24. Siracusano A., Margutti P., Delunardo F., Profumo E., Riganò R., Buttari B., Teggi A. & Ortona E. Molecular cross-talk in host–parasite relationships: the intriguing immunomodulatory role of Echinococcus antigen B in cystic echinococcosis. International Journal for Parasitology, 2008, 38 (12), 1371–1376. [CrossRef] [PubMed] [Google Scholar]
  25. Velikovsky C.A., Cassataro J., Giambartolomei G.H., Goldbaum F.A., Estein S., Bowden R.A., Bruno L., Fossati C.A. & Spitz M. DNA Vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infection and Immunity, 2002, 70 (5), 2507–2511. [CrossRef] [PubMed] [Google Scholar]
  26. Zhu W., Thomas C.E. & Sparling P.F. DNA Immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine, 2004, 22, 660–669. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.